BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo H, Wang B, Xu K, Nie L, Fu Y, Wang Z, Wang Q, Wang S, Zou X. m6A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1. Front Oncol 2020;10:553045. [PMID: 33134163 DOI: 10.3389/fonc.2020.553045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Xue C, Chu Q, Zheng Q, Jiang S, Bao Z, Su Y, Lu J, Li L. Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine. Signal Transduct Target Ther 2022;7:142. [PMID: 35484099 DOI: 10.1038/s41392-022-01003-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhao H, Xu Y, Xie Y, Zhang L, Gao M, Li S, Wang F. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer. Front Cell Dev Biol 2021;9:650023. [PMID: 33748145 DOI: 10.3389/fcell.2021.650023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Zhu F, Yang T, Yao M, Shen T, Fang C. HNRNPA2B1, as a m6A Reader, Promotes Tumorigenesis and Metastasis of Oral Squamous Cell Carcinoma. Front Oncol 2021;11:716921. [PMID: 34631545 DOI: 10.3389/fonc.2021.716921] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cai X, Liang C, Zhang M, Xu Y, Weng Y, Li X, Yu W. N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215815] [Reference Citation Analysis]
5 Lu Y, Wang X, Gu Q, Wang J, Sui Y, Wu J, Feng J. Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets. Cell Death Discov 2022;8:337. [PMID: 35879279 DOI: 10.1038/s41420-022-01129-8] [Reference Citation Analysis]
6 Huang J, Shao Y, Gu W. Function and clinical significance of N6-methyladenosine in digestive system tumours. Exp Hematol Oncol 2021;10:40. [PMID: 34246319 DOI: 10.1186/s40164-021-00234-1] [Reference Citation Analysis]
7 Wang N, Huo X, Zhang B, Chen X, Zhao S, Shi X, Xu H, Wei X. METTL3-Mediated ADAMTS9 Suppression Facilitates Angiogenesis and Carcinogenesis in Gastric Cancer. Front Oncol 2022;12:861807. [PMID: 35574388 DOI: 10.3389/fonc.2022.861807] [Reference Citation Analysis]
8 Cai Z, Niu Y, Li H. RNA N6-methyladenosine modification, spermatogenesis, and human male infertility. Mol Hum Reprod 2021;27:gaab020. [PMID: 33749751 DOI: 10.1093/molehr/gaab020] [Reference Citation Analysis]
9 Qin Z, Wang W, Ali MA, Wang Y, Zhang Y, Zhang M, Zhou G, Yang JD, Zeng C. Transcriptome-wide m6A profiling reveals mRNA post-transcriptional modification of boar sperm during cryopreservation. BMC Genomics 2021;22:588. [PMID: 34344298 DOI: 10.1186/s12864-021-07904-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Jin L, Chen C, Yao J, Yu Z, Bu L. The RNA N6 -methyladenosine modulator HNRNPA2B1 is involved in the development of non-small cell lung cancer. Clin Exp Pharmacol Physiol 2021. [PMID: 34717005 DOI: 10.1111/1440-1681.13608] [Reference Citation Analysis]
11 Guo YQ, Wang Q, Wang JG, Gu YJ, Song PP, Wang SY, Qian XY, Gao X. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression. Exp Hematol Oncol 2022;11:14. [PMID: 35287752 DOI: 10.1186/s40164-022-00256-3] [Reference Citation Analysis]
12 Jia J, Wu S, Jia Z, Wang C, Ju C, Sheng J, He F, Zhou M, He J. Novel insights into m6A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance. Int J Biol Sci 2022;18:4432-51. [PMID: 35864970 DOI: 10.7150/ijbs.73093] [Reference Citation Analysis]
13 Li J, Liu H, Dong S, Zhang Y, Li X, Wang J. ALKBH5 Is Lowly Expressed in Esophageal Squamous Cell Carcinoma and Inhibits the Malignant Proliferation and Invasion of Tumor Cells. Comput Math Methods Med 2021;2021:1001446. [PMID: 34876920 DOI: 10.1155/2021/1001446] [Reference Citation Analysis]
14 Zhang X, Lu N, Wang L, Wang Y, Li M, Zhou Y, Cui M, Zhang M, Zhang L. Recent advances of m6A methylation modification in esophageal squamous cell carcinoma. Cancer Cell Int 2021;21:421. [PMID: 34376206 DOI: 10.1186/s12935-021-02132-2] [Reference Citation Analysis]
15 Shi X, Zhang J, Jiang Y, Zhang C, Luo X, Wu J, Li J. Comprehensive Analyses of the Expression, Genetic Alteration, Prognosis Significance, and Interaction Networks of m6A Regulators Across Human Cancers. Front Genet 2021;12:771853. [PMID: 35003212 DOI: 10.3389/fgene.2021.771853] [Reference Citation Analysis]
16 Zhang W, Xiao P, Tang J, Wang R, Wang X, Wang F, Ruan J, Yu S, Tang J, Huang R, Zhao X. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment. Front Immunol 2022;13:888650. [DOI: 10.3389/fimmu.2022.888650] [Reference Citation Analysis]
17 Song N, Cui K, Zhang K, Yang J, Liu J, Miao Z, Zhao F, Meng H, Chen L, Chen C, Li Y, Shao M, Zhang J, Wang H. The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research. Front Pharmacol 2022;13:933332. [DOI: 10.3389/fphar.2022.933332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li L, Xie R, Wei Q. Network analysis of miRNA targeting m6A-related genes in patients with esophageal cancer. PeerJ 2021;9:e11893. [PMID: 34395102 DOI: 10.7717/peerj.11893] [Reference Citation Analysis]
19 Li K, Chen J, Lou X, Li Y, Qian B, Xu D, Wu Y, Ma S, Zhang D, Cui W. HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster. Front Cell Dev Biol 2021;9:658642. [PMID: 34277606 DOI: 10.3389/fcell.2021.658642] [Reference Citation Analysis]
20 Yu D, Pan M, Li Y, Lu T, Wang Z, Liu C, Hu G. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. J Exp Clin Cancer Res 2022;41:6. [PMID: 34980207 DOI: 10.1186/s13046-021-02212-1] [Reference Citation Analysis]
21 Li J, Zhu H, Yang Q, Xiao H, Wu H, Fang Z, Li W, Cai M, Wang F. Identification of Molecular Subtypes and Potential Small-Molecule Drugs for Esophagus Cancer Treatment Based on m6A Regulators. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/5490461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang Z, Wang F, Zhang J, Zhan W, Zhang G, Li C, Zhang T, Yuan Q, Chen J, Guo M, Xu H, Yu F, Wang H, Wang X, Kong W. An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma. Front Pharmacol 2022;13:854851. [PMID: 35431958 DOI: 10.3389/fphar.2022.854851] [Reference Citation Analysis]
23 An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer 2022;21:14. [PMID: 35022030 DOI: 10.1186/s12943-022-01500-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
24 Zhang F, Liu H, Duan M, Wang G, Zhang Z, Wang Y, Qian Y, Yang Z, Jiang X. Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application. J Hematol Oncol 2022;15. [DOI: 10.1186/s13045-022-01304-5] [Reference Citation Analysis]
25 Maldonado López A, Capell BC. The METTL3-m6A Epitranscriptome: Dynamic Regulator of Epithelial Development, Differentiation, and Cancer. Genes (Basel) 2021;12:1019. [PMID: 34209046 DOI: 10.3390/genes12071019] [Reference Citation Analysis]